KURA ONCOLOGY, INC. Basic Shares Outstanding (Weighted Average)
KURA ONCOLOGY, INC. (KURA) reported Basic Shares Outstanding (Weighted Average) of 88.86 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- KURA ONCOLOGY, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 88.86M shares, a 1.45% increase year-over-year.
- KURA ONCOLOGY, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 88.61M shares, a 1.37% increase year-over-year.
- KURA ONCOLOGY, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 88.05M shares, a 1.05% increase year-over-year.
- KURA ONCOLOGY, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 87.64M shares, a 0.80% increase year-over-year.
- KURA ONCOLOGY, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 87.68M shares, a 1.76% increase from fiscal 2024.
- KURA ONCOLOGY, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 86.16M shares, a 17.66% increase from fiscal 2023.
- KURA ONCOLOGY, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 73.23M shares, a 9.31% increase from fiscal 2022.
- KURA ONCOLOGY, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 66.99M shares, a 0.96% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 88.86M shares 10-Q · filed 2026-08-12 | 88.73M shares 10-Q · filed 2026-08-12 | 88.51M shares derived: average of 3 quarters · filed 2026-08-12 | 88.29M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 88.61M shares 10-Q · filed 2026-05-12 | 88.33M shares derived: average of 2 quarters · filed 2026-05-12 | 88.10M shares derived: average of 3 quarters · filed 2026-05-12 | 87.97M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 88.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 87.85M shares derived: average of 2 quarters · filed 2026-03-05 | 87.76M shares derived: average of 3 quarters · filed 2026-08-12 | 87.68M shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 87.64M shares 10-Q · filed 2025-11-04 | 87.62M shares derived: average of 2 quarters · filed 2026-08-12 | 87.55M shares 10-Q · filed 2025-11-04 | 87.45M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 87.59M shares 10-Q · filed 2026-08-12 | 87.50M shares 10-Q · filed 2026-08-12 | 87.38M shares derived: average of 3 quarters · filed 2026-08-12 | 87.27M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 87.42M shares 10-Q · filed 2026-05-12 | 87.28M shares derived: average of 2 quarters · filed 2026-05-12 | 87.17M shares derived: average of 3 quarters · filed 2026-05-12 | 87.04M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 87.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 87.05M shares derived: average of 2 quarters · filed 2026-03-05 | 86.91M shares derived: average of 3 quarters · filed 2026-03-05 | 86.16M shares 10-K · filed 2026-03-05 |
| 2024-09-30 | 86.95M shares 10-Q · filed 2025-11-04 | 86.79M shares derived: average of 2 quarters · filed 2025-11-04 | 85.83M shares 10-Q · filed 2025-11-04 | 83.72M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | 86.64M shares 10-Q · filed 2025-08-07 | 85.27M shares 10-Q · filed 2025-08-07 | 82.64M shares derived: average of 3 quarters · filed 2026-03-05 | 81.29M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | 83.91M shares 10-Q · filed 2025-05-01 | 80.64M shares derived: average of 2 quarters · filed 2026-03-05 | 79.51M shares derived: average of 3 quarters · filed 2026-03-05 | 77.08M shares derived: average of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | 77.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 77.31M shares derived: average of 2 quarters · filed 2026-03-05 | 74.81M shares derived: average of 3 quarters · filed 2026-03-05 | 73.23M shares 10-K · filed 2026-03-05 |
| 2023-09-30 | 77.24M shares 10-Q · filed 2024-11-07 | 73.52M shares derived: average of 2 quarters · filed 2024-11-07 | 71.84M shares 10-Q · filed 2024-11-07 | 70.81M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | 69.80M shares 10-Q · filed 2024-08-08 | 69.10M shares 10-Q · filed 2024-08-08 | 68.66M shares derived: average of 3 quarters · filed 2025-02-28 | 68.22M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | 68.40M shares 10-Q · filed 2024-05-02 | 68.10M shares derived: average of 2 quarters · filed 2025-02-28 | 67.69M shares derived: average of 3 quarters · filed 2025-02-28 | 67.44M shares derived: average of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | 67.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 67.34M shares derived: average of 2 quarters · filed 2025-02-28 | 67.12M shares derived: average of 3 quarters · filed 2025-02-28 | 66.99M shares 10-K · filed 2025-02-28 |
| 2022-09-30 | 66.89M shares 10-Q · filed 2023-11-02 | 66.78M shares derived: average of 2 quarters · filed 2023-11-02 | 66.72M shares 10-Q · filed 2023-11-02 | 66.68M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | 66.67M shares 10-Q · filed 2023-08-09 | 66.64M shares 10-Q · filed 2023-08-09 | 66.61M shares derived: average of 3 quarters · filed 2024-02-27 | 66.55M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | 66.61M shares 10-Q · filed 2023-05-10 | 66.58M shares derived: average of 2 quarters · filed 2024-02-27 | 66.50M shares derived: average of 3 quarters · filed 2024-02-27 | 66.45M shares derived: average of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | 66.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 66.45M shares derived: average of 2 quarters · filed 2024-02-27 | 66.40M shares derived: average of 3 quarters · filed 2024-02-27 | 66.35M shares 10-K · filed 2024-02-27 |
| 2021-09-30 | 66.35M shares 10-Q · filed 2022-11-03 | 66.32M shares derived: average of 2 quarters · filed 2022-11-03 | 66.28M shares 10-Q · filed 2022-11-03 | |
| 2021-06-30 | 66.28M shares 10-Q · filed 2022-08-03 | 66.25M shares 10-Q · filed 2022-08-03 | ||
| 2020-12-31 | 53.08M shares 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |